tiprankstipranks
Advertisement
Advertisement
Agomab initiated with a Buy at H.C. Wainwright
PremiumThe FlyAgomab initiated with a Buy at H.C. Wainwright
1M ago
Premium
Company Announcements
Agomab Shareholders Approve All 2025 Accounts and Board Reappointments at May 26 AGM
2M ago
Premium
Company Announcements
Agomab Posts 2025 Loss, Fortifies Cash After IPO and Targets Key 2026 Trial Milestones
3M ago
Agomab initiated with an Overweight at JPMorgan
PremiumThe FlyAgomab initiated with an Overweight at JPMorgan
5M ago
Opening Day: Generate Biomedicines makes public debut
Premium
The Fly
Opening Day: Generate Biomedicines makes public debut
5M ago
Premium
Company Announcements
AgomAb Therapeutics Closes Nasdaq IPO of 12.5 Million ADSs
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100